Vivacell, biotech start-up in Chicago, receives FDA approval for Phase IIa Clinical Trials

by Shubha Ghosh, PhD, JD, Crandall Melvin Professor of Law and Director, IP and Tech Commercialization Curricular Program & SIPLI

Harven DeShield, JD, PhD, and general counsel for Vivacell, a Chicago biotech start-up, visited us October, 2018, to talk about his academic and legal work that led to the technology underlying the company, which recently received FDA approval for Phase IIA Clinical Trials.

Share this!